For the second quarter ended
"Although historically our second quarter suffers from a seasonality effect which typically lowers revenue, the revenue increased by 4% in comparison to the first quarter of 2014, resulting in an overall increase of 4.6% in gross margin over the same period," stated
Caution Regarding Forward-Looking Statements - This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.
FOR FURTHER INFORMATION PLEASE CONTACT:
NexgenRx Inc. Ronald C. LoucksPresident and CEO 416.695.3393 x801 NexgenRx Inc. Taba MerrikhDirector of Finance 416-695-3393 x803 www.nexgenrx.com Source: NexgenRx Inc.